ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

HCFA Chief Says Facts Will Not Matter, She Won’t Loosen DRGs For Clinical Trials Unless Congress Orders It

May 4, 1984

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

Funding opportunities listed.

November 19, 2004

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

NCI To Offer Planning Grants for New Centers

November 9, 1990